Tianda Pharmaceuticals Limited (HKG:0455)

Tianda Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Mar 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022	Mar 31, 2021
Market Capitalization	213	363	469	871	501	434
Market Cap Growth	-46.49%	-22.48%	-46.17%	73.82%	15.35%	26.25%
Enterprise Value	250	358	380	787	493	311
Last Close Price	0.10	0.17	0.21	0.39	0.21	0.18
Forward PE	-	6.55	6.55	6.55	6.55	6.55
PS Ratio	0.69	1.10	0.88	1.59	0.98	0.92
PB Ratio	0.44	0.72	0.79	1.33	0.64	0.55
P/TBV Ratio	0.64	0.94	0.95	1.64	0.79	0.69
P/FCF Ratio	9.21	-	-	12.69	-	-
P/OCF Ratio	4.80	-	-	8.55	-	-
EV/Sales Ratio	0.80	1.09	0.71	1.44	0.97	0.66
EV/FCF Ratio	10.80	-	-	11.47	-	-
Debt / Equity Ratio	0.28	0.25	0.19	0.22	0.20	0.18
Debt / EBITDA Ratio	-	-	20.85	-	-	-
Debt / FCF Ratio	5.86	-	-	2.06	-	-
Net Debt / Equity Ratio	0.08	0.07	-0.10	-0.34	-0.24	-0.12
Net Debt / EBITDA Ratio	-1.21	-1.46	60.10	8.04	6.46	4.44
Net Debt / FCF Ratio	1.61	-1.17	0.58	-3.27	3.09	0.50
Asset Turnover	0.39	0.39	0.53	-	0.44	0.46
Inventory Turnover	2.84	3.38	4.88	-	3.86	3.82
Quick Ratio	0.68	0.69	0.89	1.40	1.83	1.80
Current Ratio	0.91	0.86	1.10	1.54	2.13	2.83
Return on Equity (ROE)	-13.15%	-11.19%	-4.01%	-	-2.74%	-3.34%
Return on Assets (ROA)	-4.85%	-4.02%	-1.81%	-	-2.40%	-2.08%
Return on Invested Capital (ROIC)	-11.72%	-10.06%	-6.02%	-13.65%	-6.81%	-5.88%
Return on Capital Employed (ROCE)	-11.30%	-10.50%	-4.80%	-9.70%	-4.90%	-3.70%
Earnings Yield	-31.65%	-16.89%	-5.15%	-6.27%	-3.95%	-6.25%
FCF Yield	10.86%	-8.34%	-21.13%	7.88%	-12.37%	-42.21%
Dividend Yield	-	-	1.22%	0.89%	1.21%	1.42%
Total Shareholder Return	-	-	1.22%	0.89%	1.21%	1.42%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.